PFIZER INC — Director's Dealing 2022

Mar 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2022-02-26

Reporting Person: BOURLA ALBERT (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-26	Common Stock	F	21824.0000	$47.7200	Disposed	188017.0000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4016.0000	Indirect

Footnotes

F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).

F2: Price is the closing price of Pfizer common stock on February 25, 2022.